OPTERA THERAPEUTICS Trademark

Trademark Overview


On Wednesday, October 4, 2017, a trademark application was filed for OPTERA THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the OPTERA THERAPEUTICS trademark a serial number of 87633074. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 30, 2019. This trademark is owned by Optera Therapeutics Corp.. The OPTERA THERAPEUTICS trademark is filed in the Chemical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Cells for scientific and research purposes in the fields of immunotherapies and treatment of diseases; reagents for scientific and medical research, treatment discovery and development, and clinical laboratory use

Medical research services in the field of cancer and other diseases; scientific research services in the fields of oncology and immunotherapy treatments; biochemical and biological research and analysis for others; medical research in the fields of immunotherapy, cell therapy, immune cell therapy and t-cell therapy

Medical services; medical services relating to the treatment of cancer; medical services, namely, isolation, collection and banking of t-cells for the treatment of cancer and other diseases and medical conditions; health care services, namely, providing immunotherapy treatments; medical testing for diagnostic and treatment purposes
optera therapeutics

General Information


Serial Number87633074
Word MarkOPTERA THERAPEUTICS
Filing DateWednesday, October 4, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 30, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 2, 2019

Trademark Statements


Disclaimer with Predetermined Text"THERAPEUTICS"
Goods and ServicesCells for scientific and research purposes in the fields of immunotherapies and treatment of diseases; reagents for scientific and medical research, treatment discovery and development, and clinical laboratory use
Goods and ServicesMedical research services in the field of cancer and other diseases; scientific research services in the fields of oncology and immunotherapy treatments; biochemical and biological research and analysis for others; medical research in the fields of immunotherapy, cell therapy, immune cell therapy and t-cell therapy
Goods and ServicesMedical services; medical services relating to the treatment of cancer; medical services, namely, isolation, collection and banking of t-cells for the treatment of cancer and other diseases and medical conditions; health care services, namely, providing immunotherapy treatments; medical testing for diagnostic and treatment purposes

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateWednesday, October 11, 2017
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, October 11, 2017
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, October 11, 2017
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameOptera Therapeutics Corp.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressEmeryville, CA 94608

Party NameOptera Therapeutics Corp.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressEmeryville, CA 94608

Trademark Events


Event DateEvent Description
Monday, December 30, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, December 30, 2019ABANDONMENT - NO USE STATEMENT FILED
Tuesday, May 28, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 2, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 2, 2019PUBLISHED FOR OPPOSITION
Wednesday, March 13, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, February 22, 2019ASSIGNED TO LIE
Thursday, February 7, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, February 7, 2019EXAMINER'S AMENDMENT ENTERED
Thursday, February 7, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, February 7, 2019EXAMINERS AMENDMENT E-MAILED
Thursday, February 7, 2019EXAMINERS AMENDMENT -WRITTEN
Friday, August 10, 2018NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, August 10, 2018FINAL REFUSAL E-MAILED
Friday, August 10, 2018FINAL REFUSAL WRITTEN
Friday, July 13, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, July 12, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 12, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 14, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, March 14, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, January 12, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, January 12, 2018NON-FINAL ACTION E-MAILED
Friday, January 12, 2018NON-FINAL ACTION WRITTEN
Friday, January 12, 2018ASSIGNED TO EXAMINER
Wednesday, October 11, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, October 7, 2017NEW APPLICATION ENTERED IN TRAM